Bienaime Jean Jacques
Immunome, Inc. · Director
Bienaime Jean Jacques is listed in filings as Director at Immunome, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2026, including purchase activity and sale activity. Recent filings connect the profile to Immunome, Inc. (IMNM), Keros Therapeutics, Inc. (KROS), Incyte Corp (INCY), and Ascendis Pharma A/S (ASND). The current snapshot covers public activity from Jun 18, 2024 to Jun 9, 2026. Reported amounts are shown as $19.3K to $116.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $19k1k shares | BuyJun 5, 2026 | $19.27 | $22.20 | |
| $68k3.5k shares | BuyJun 5, 2026 | $19.46 | $22.20 | |
| $117k6k shares | BuyJun 5, 2026 | $19.48 | $22.20 | |
| $194k10k shares | SellJun 5, 2026 | $19.41 | $22.20 | |
| $9.7k500 shares | SellJun 5, 2026 | $19.44 | $22.20 |